Orchid gets three final bids at par with liquidation value

The company had to sell assets to rein in debt. In 2012, it sold its penicillin business to US drug maker Hospira for $200 million.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news